Exelixis
EXEL
#1592
Rank
$10.68 B
Marketcap
$38.17
Share price
-1.24%
Change (1 day)
71.47%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company